Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients

INTRODUCTION: Acute respiratory distress syndrome (ARDS) is challenging in the intensive care unit (ICU). Although pharmacotherapy for ARDS has gained increasing attention, most trials have yielded negative results. Patients with ARDS have usually been recruited as subjects; the inflammatory reactio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zongyu, Tao, Liyuan, Yan, Yingying, Zhu, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429909/
https://www.ncbi.nlm.nih.gov/pubmed/30850411
http://dx.doi.org/10.1136/bmjopen-2018-025523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429909/
https://www.ncbi.nlm.nih.gov/pubmed/30850411
http://dx.doi.org/10.1136/bmjopen-2018-025523

Ejemplares similares